The company's experimental reasoning model wasn't fine-tuned to solve math problems, but was trained as a general ...

Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia Pre-Supplemental New Drug Applicat ...